Marking European Testing Week: ECDC issues integrated hepatitis and HIV testing Guidance
To mark European Testing Week from 23 to 30 November 2018, ECDC publishes its new Guidance on integrated viral hepatitis and HIV testing.
WHO: Action plan for the health sector response to viral hepatitis in the WHO European Region
This first Action plan for viral hepatitis in the WHO European Region adapts the Global health sector strategy on viral hepatitis, 2016–2021 to the context of the European Region. The goal of the Action plan is elimination of viral hepatitis as a public health threat in the WHO European Region by 2030 through the reduction of transmission, morbidity and mortality due to viral hepatitis and its complications, and by ensuring equitable access to comprehensive prevention, recommended testing, care and treatment services for all.
Chronic hepatitis B infections on the rise since 2008
In 2017, the majority (58%) of the almost 27 000 newly reported hepatitis B cases in the European Union and European Economic Area were classified as chronic infections. This follows a consistent upward trend in reported chronic hepatitis B cases since 2008.
Options for national testing and surveillance for hepatitis E virus in the EU/EEA - Operational guidance
This operational guidance, developed by ECDC in collaboration with its hepatitis E virus (HEV) expert group, offers options on the implementation or adjustment of HEV surveillance at a national level.
Travel-associated hepatitis A in Europe, 2009 to 2015
Beauté, J., Westrell, T., Schmid, D., Müller, L., Epstein, J., Kontio, M., Couturier, E., Faber, M., Mellou, K., Borg, M.-L., Friesema, I., Vold, L., Severi, E.